Posts by Jagmeet P. Singh, MD, PhD
-
New Book Envisions the Future of Digital Health
A Massachusetts General Hospital author describes how sensors and artificial intelligence (AI) in healthcare can revolutionize the current model and maximize preventive medicine.
-
CRT Improves Left Ventricular Function for Chemotherapy-Induced Cardiomyopathy Patients
Patients with chemotherapy-induced cardiomyopathy who received cardiac resynchronization therapy saw improved left ventricular function.
-
Dual-Biomarker Strategy Helps Identify Nonresponders to Cardiac Resynchronization
Measurement of two blood-based biomarkers can identify patients with heart failure that are at risk of nonresponse to cardiac resynchronization therapy and major adverse cardiovascular events afterward.
-
LV Lead Location Affects Long-Term Outcomes of Cardiac Resynchronization Therapy
A post hoc analysis of the MADIT-CRT trial showed that long-term outcomes differ according to left ventricular lead location, as well as by the presence of left bundle branch block at baseline.
-
Progressive Digital and Wearable Landscape Expands Horizons for EPs’ to Provide Continuous Patient Care
In an editorial, Jagmeet Singh, MD, PhD, highlights the progressive trend in connected devices to manage patient care and the need for a cultural shift electrophysiologists’ clinical practice.
-
Atrial Fibrillation and Heart Failure Prevention: Do We Need a Risk Score?
Atrial fibrillation (AF) and heart failure (HF) as individual cardiac conditions are associated with morbidity and mortality in epidemic proportions. With at least 3 million patients with AF and 5 million with HF in the United States, the clinical effect and the health economic burden cannot be underestimated.
-
Advances in Heart Failure Management
Conventional strategies and emerging novel therapies offer clinicians a management suite to offset the rising toll from heart failure.
Biography
Jag Singh, MD, PhD, is attending physician in the Telemachus & Irene Demoulas Family Foundation Center for Cardiac Arrhythmias at the Massachusetts General Hospital Heart Center. Dr. Singh received his medical degree from BJ Medical College, Pune University, India. He completed his internal medicine residency, cardiology and cardiac electrophysiology fellowships at Mass General. He also earned a doctorate from Oxford University, a master of science in clinical investigation from MIT and a research fellowship at the Framingham Heart Study. He is a Professor of Medicine at Harvard Medical School.
Dr. Singh's research interests are in clinical cardiac electrophysiology, with an emphasis on device therapy for heart failure and catheter ablation of atrial fibrillation. His investigative work has focused on improving patient selection strategies, multimodality imaging, lead implantation techniques and follow-up protocols for patients receiving device therapy. Dr. Singh is the national principal investigator on 5 ongoing multi-center clinical trials and is also a member of steering committees for over 20 single and multicenter research studies. He also directs the coronary venous angiography core laboratory for several multicenter research studies. Dr. Singh is on the editorial board of several medical journals, Deputy Editor of the Journal of American College of Cardiology: Clinical EP and editor-in-chief of the Current Treatment Options in Cardiovascular Medicine. Dr. Singh is an internationally recognized speaker and frequently gives lectures at national and international educational forums. Dr. Singh has over 200 publications inclusive of original research articles, clinical communications, text book chapters, review articles and editorials. He has edited a Textbook on Imaging in Electrophysiology.
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.